Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Israeli lawmakers pass bill reviving death penalty for terrorists - 2Expert advice for new stargazers: How to begin your amateur astronomy journey
- 3Authorities Bust Camel Booze Smuggling Operation, Seize Nearly 2,000 Containers of Illegal Alcohol
- 4Iran denies launching ballistic missiles towards Kurdistan region of Iraq
- 55 Worldwide Road Food varieties You Should Attempt
- Israel intensifies Lebanon attacks and hits areas not in Hezbollah's control
- I’m a doctor. Here are 10 science-backed tips to help you get healthier.
- Guaranteeing Quality Medical care with Federal medical care Benefit Plans.
- World’s tallest bridge and biggest museum named ‘greatest places of 2026’
- Map shows more than 1,900 measles cases across U.S.
- US FDA approves Kura-Kyowa's blood cancer therapy
- 10 Fundamental Tips and Deceives to Lift Your Cell phone's Exhibition
- Equality requires universal draft, participation in economy and workforce, MK Liberman says
- Step by step instructions to Utilize Open Record Rewards for Your Potential benefit
